Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: AmerisourceBergen Corporation
Current Parent Company: Cencora Inc.
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $625,000,000
Year: 2018
Date: October 1, 2018
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: drug or medical equipment safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: AmerisourceBergen Corporation and its subsidiaries AmerisourceBergen Specialty Group, AmerisourceBergen Drug Corporation, Oncology Supply Company, and Medical Initiatives Inc. agreed to pay $625 million to resolve allegations arising from its operation of a facility that improperly repackaged oncology-supportive injectable drugs into pre-filled syringes and improperly distributed those syringes to physicians treating vulnerable cancer patients.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: Pennsylvania
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: wholesalers
Specific Industry of Current Parent: wholesalers-pharmaceuticals
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.